Glycobiology of Human Fungal Pathogens: New Avenues for Drug Development

Danielle J Lee1, Holly O'Donnell2, Françoise H Routier3

  • 1Institute for Glycomics, Griffith University, Gold Coast Campus, Queensland, 4222, Australia; Member of Fraunhofer International Consortium for Anti-Infective Research (iCAIR), Nikolai-Fuchs Strasse 1, 30625 Hannover, Germany. danielle.lee2@griffithuni.edu.au.

Cells
|November 2, 2019
PubMed

Insights

Invasive fungal infections (IFI) are a growing threat. Targeting fungal cell wall glycobiology, specifically nucleotide sugar transporters (NSTs), offers a promising strategy for developing novel antifungal treatments and combating drug resistance.

Area of Science:

  • Medical Mycology
  • Molecular Biology
  • Glycobiology

Background:

  • Invasive fungal infections (IFI) pose a significant global health challenge, exacerbated by compromised immune systems and increasing drug resistance.
  • Fungal spores are ubiquitous, and opportunistic pathogens can cause disease when host defenses are weakened or the normal microbiota is disrupted.

Purpose of the Study:

  • To review the prevalence and treatment options for IFIs, with a focus on antifungal drug resistance.
  • To elucidate the role of fungal glycobiology, particularly cell wall components, in pathogenicity.
  • To explore nucleotide sugar transporters (NSTs) as potential targets for novel antifungal therapies.

Main Methods:

  • Literature review of current IFI prevalence, treatments, and drug resistance.
  • Analysis of fungal cell wall glycobiology, including polysaccharide and glycoconjugate biosynthesis.
  • Examination of the function and potential inhibition of nucleotide sugar transporters (NSTs) in fungal pathogens.

Main Results:

  • Fungal cell wall polysaccharides and glycoconjugates are critical for pathogenicity.
  • Nucleotide sugar transporters (NSTs) play a vital role in fungal survival and virulence.
  • Existing antifungal treatments face challenges due to emerging drug resistance.

Conclusions:

  • Understanding fungal glycobiology is key to developing effective IFI treatments.
  • Inhibiting fungal NSTs presents a promising avenue for novel antifungal drug development.
  • Targeting specific molecular pathways, like NSTs, may overcome current antifungal resistance issues.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
360
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
922
Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
9.1K
Overview of Fungi01:29

Overview of Fungi

Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
1.4K